Genetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab LEUKEMIA & LYMPHOMA Weng, W. K., Levy, R. 2009; 50 (5:723-727)